BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 1443170)

  • 1. Rat kidney aldose reductase and aldehyde reductase and polyol production in rat kidney.
    Sato S
    Am J Physiol; 1992 Nov; 263(5 Pt 2):F799-805. PubMed ID: 1443170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human kidney aldose and aldehyde reductases.
    Sato S; Kador PF
    J Diabetes Complications; 1993; 7(3):179-87. PubMed ID: 8343612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyol effects on growth factors and MAPK signaling in rat retinal capillary cells.
    Zhang P; Zhang Z; Kador PF
    J Ocul Pharmacol Ther; 2014 Feb; 30(1):4-11. PubMed ID: 24256145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
    Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified rat lens aldose reductase. Polyol production in vitro and its inhibition by aldose reductase inhibitors.
    Kador PF; Kinoshita JH; Brittain DR; Mirrlees DJ; Sennitt CM; Stribling D
    Biochem J; 1986 Nov; 240(1):233-7. PubMed ID: 3030278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of Zopolrestat and Sorbinil on lens myo-inositol influx.
    Beyer-Mears A; Diecke FP; Mistry K; Cruz E
    Pharmacology; 1997 Feb; 54(2):76-83. PubMed ID: 9088040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrinsic inhibition of aldose reductase.
    Kador PF; Sun G; Rait VK; Rodriguez L; Ma Y; Sugiyama K
    J Ocul Pharmacol Ther; 2001 Aug; 17(4):373-81. PubMed ID: 11572468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyol formation and NADPH-dependent reductases in dog retinal capillary pericytes and endothelial cells.
    Sato S; Secchi EF; Lizak MJ; Fukase S; Ohta N; Murata M; Tsai JY; Kador PF
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):697-704. PubMed ID: 10067973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for existence of polyol pathway in cultured rat mesangial cells.
    Kikkawa R; Umemura K; Haneda M; Arimura T; Ebata K; Shigeta Y
    Diabetes; 1987 Feb; 36(2):240-3. PubMed ID: 3100369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH-dependent reductases and polyol formation in human leukemia cell lines.
    Sato S; Secchi EF; Sakurai S; Ohta N; Fukase S; Lizak MJ
    Chem Biol Interact; 2003 Feb; 143-144():363-71. PubMed ID: 12604223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyol accumulation in cultured human lens epithelial cells.
    Lin LR; Reddy VN; Giblin FJ; Kador PF; Kinoshita JH
    Exp Eye Res; 1991 Jan; 52(1):93-100. PubMed ID: 1907924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-FG as substrate for investigating flux through the polyol pathway in dog lens by 19F-NMR spectroscopy.
    Lizak MJ; Secchi EF; Lee JW; Sato S; Kubo E; Akagi Y; Kador PF
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2688-95. PubMed ID: 9856779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.
    Malamas MS; Hohman TC; Millen J
    J Med Chem; 1994 Jun; 37(13):2043-58. PubMed ID: 8027986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldose reductase, a key enzyme in the oxidative deamination of norepinephrine in rats.
    Kawamura M; Eisenhofer G; Kopin IJ; Kador PF; Lee YS; Tsai JY; Fujisawa S; Lizak MJ; Sinz A; Sato S
    Biochem Pharmacol; 1999 Aug; 58(3):517-24. PubMed ID: 10424772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of aldose reductase activity in the eye by localized magnetic resonance spectroscopy.
    Lizak MJ; Mori K; Kador PF
    J Ocul Pharmacol Ther; 2001 Oct; 17(5):475-83. PubMed ID: 11765152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor.
    Obrosova I; Faller A; Burgan J; Ostrow E; Williamson JR
    Curr Eye Res; 1997 Jan; 16(1):34-43. PubMed ID: 9043821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyol and water accumulation in muscle of galactose-fed rats.
    Griffey RH; Sibbitt WL; Sibbitt RR; Griffey BV; Eaton RP; Hunsaker LA; Vander Jagt DL
    Biochem Pharmacol; 1994 Nov; 48(9):1839-41. PubMed ID: 7980654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.